AT383123B - Verfahren zur herstellung von neuen (+)-catechin- alpha- monohydrat - Google Patents

Verfahren zur herstellung von neuen (+)-catechin- alpha- monohydrat

Info

Publication number
AT383123B
AT383123B AT0062083A AT62083A AT383123B AT 383123 B AT383123 B AT 383123B AT 0062083 A AT0062083 A AT 0062083A AT 62083 A AT62083 A AT 62083A AT 383123 B AT383123 B AT 383123B
Authority
AT
Austria
Prior art keywords
catechin
producing new
alpha monohydrate
monohydrate
pharmaceutical preparations
Prior art date
Application number
AT0062083A
Other languages
English (en)
Other versions
ATA62083A (de
Original Assignee
Zyma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zyma Sa filed Critical Zyma Sa
Publication of ATA62083A publication Critical patent/ATA62083A/de
Application granted granted Critical
Publication of AT383123B publication Critical patent/AT383123B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT0062083A 1982-02-24 1983-02-23 Verfahren zur herstellung von neuen (+)-catechin- alpha- monohydrat AT383123B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8205453 1982-02-24

Publications (2)

Publication Number Publication Date
ATA62083A ATA62083A (de) 1986-10-15
AT383123B true AT383123B (de) 1987-05-25

Family

ID=10528576

Family Applications (2)

Application Number Title Priority Date Filing Date
AT83101707T ATE27456T1 (de) 1982-02-24 1983-02-22 Kristallinische aenderungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.
AT0062083A AT383123B (de) 1982-02-24 1983-02-23 Verfahren zur herstellung von neuen (+)-catechin- alpha- monohydrat

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT83101707T ATE27456T1 (de) 1982-02-24 1983-02-22 Kristallinische aenderungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.

Country Status (30)

Country Link
US (1) US4515804A (de)
EP (1) EP0087164B1 (de)
JP (1) JPS58185578A (de)
KR (1) KR900006557B1 (de)
AT (2) ATE27456T1 (de)
AU (1) AU566685B2 (de)
BE (1) BE895991A (de)
CA (1) CA1212381A (de)
CH (1) CH654004A5 (de)
DD (1) DD208613A5 (de)
DE (2) DE3306092A1 (de)
DK (1) DK80983A (de)
ES (1) ES8504977A1 (de)
FI (1) FI76330C (de)
FR (1) FR2521995A1 (de)
GB (1) GB2115409B (de)
GR (1) GR77918B (de)
HU (1) HU194854B (de)
IL (1) IL67969A (de)
IN (1) IN157218B (de)
IT (1) IT1197582B (de)
LU (1) LU84657A1 (de)
NL (1) NL8300600A (de)
NO (1) NO830629L (de)
NZ (1) NZ203369A (de)
PH (1) PH20689A (de)
PL (1) PL141809B1 (de)
PT (1) PT76279B (de)
SE (1) SE8300974L (de)
ZA (1) ZA831216B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59219384A (ja) * 1983-05-30 1984-12-10 Mitsui Norin Kk 天然抗酸化剤の製造方法
JPS6013780A (ja) * 1983-07-05 1985-01-24 Mitsui Norin Kk 茶カテキン類の製造方法
IT1180507B (it) * 1984-06-29 1987-09-23 Roberto Valducci Procedimento per la preparazione di etofibrato o sostanze di pari o simili caratteristiche, in microgunuli-ritardo e prodotto ottenuto con tale procedimento
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
JPH01500113A (ja) * 1986-04-07 1989-01-19 クレメトソン，チヤールズ，エー．，ビー． カテキンで被覆されたアスコルビン酸及び方法
DE4316347C1 (de) * 1993-02-26 1994-08-18 Ina Dr Levi Verfahren zur Herstellung einer pharmazeutischen Zubereitung und Verwendung derselben zur Behandlung bestimmter Erkrankungen
WO1994022322A1 (en) * 1993-04-01 1994-10-13 Kalamazoo Holdings, Inc. Solid microcrystalline green tea catechin antioxidants for lipids
US7108868B2 (en) 2002-03-22 2006-09-19 Unigen Pharmaceuticals, Inc. Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
US7972632B2 (en) 2003-02-28 2011-07-05 Unigen Pharmaceuticals, Inc. Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors
DE60328676D1 (de) * 2002-04-30 2009-09-17 Unigen Pharmaceuticals Inc Formulierung eines gemisches aus flavonoiden und flavanen mit freiem b ring als therapeutisches mittel
US8034387B2 (en) * 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
US8945518B2 (en) * 2002-04-30 2015-02-03 Unigen, Inc. Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions
AU2004228021B2 (en) * 2003-04-04 2010-09-02 Unigen, Inc. Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care
KR100545304B1 (ko) * 2004-09-01 2006-05-08 주식회사 유니젠 아선약을 포함하는 운카리아 속 식물, 또는 이의 황금및/또는 녹차의 배합물을 포함하는 사이클로옥시게나제및/또는 5-리폭시게나제 억제용 조성물
CN101747305B (zh) * 2008-11-28 2014-06-18 中国医学科学院药物研究所 硝克柳胺化合物晶v型、其制法和其药物组合物与用途
US11974982B2 (en) 2020-04-03 2024-05-07 The Board Of Trustees Of The University Of Illinois Stimulus-responsive antioxidant crystals and method for their preparation

Also Published As

Publication number Publication date
EP0087164A1 (de) 1983-08-31
KR900006557B1 (ko) 1990-09-13
HU194854B (en) 1988-03-28
SE8300974L (sv) 1983-08-25
EP0087164B1 (de) 1987-05-27
FI830571L (fi) 1983-08-25
CH654004A5 (de) 1986-01-31
JPH032154B2 (de) 1991-01-14
KR840003625A (ko) 1984-09-15
BE895991A (fr) 1983-08-23
IT1197582B (it) 1988-12-06
CA1212381A (en) 1986-10-07
PL240734A1 (en) 1984-11-08
PH20689A (en) 1987-03-24
IN157218B (de) 1986-02-15
IL67969A (en) 1986-11-30
IT8347760A0 (it) 1983-02-22
US4515804A (en) 1985-05-07
FR2521995B1 (de) 1984-09-07
DE3371785D1 (en) 1987-07-02
PT76279A (en) 1983-03-01
PT76279B (en) 1986-03-19
DD208613A5 (de) 1984-04-04
GB2115409B (en) 1985-08-07
ZA831216B (en) 1985-03-27
FI76330C (fi) 1988-10-10
ATE27456T1 (de) 1987-06-15
GB2115409A (en) 1983-09-07
ES519982A0 (es) 1985-04-16
FI830571A0 (fi) 1983-02-21
JPS58185578A (ja) 1983-10-29
GR77918B (de) 1984-09-25
DK80983D0 (da) 1983-02-23
IL67969A0 (en) 1983-06-15
NL8300600A (nl) 1983-09-16
GB8302562D0 (en) 1983-03-02
LU84657A1 (de) 1983-09-08
ATA62083A (de) 1986-10-15
AU1178583A (en) 1983-09-01
ES8504977A1 (es) 1985-04-16
FI76330B (fi) 1988-06-30
DE3306092A1 (de) 1983-09-01
DK80983A (da) 1983-08-25
FR2521995A1 (fr) 1983-08-26
PL141809B1 (en) 1987-08-31
NZ203369A (en) 1986-03-14
AU566685B2 (en) 1987-10-29
NO830629L (no) 1983-08-25
SE8300974D0 (sv) 1983-02-22

Similar Documents

Publication Publication Date Title
AT383123B (de) Verfahren zur herstellung von neuen (+)-catechin- alpha- monohydrat
ATA28687A (de) Verfahren zur herstellung von neuen dichloranilinderivaten
AT385755B (de) Verfahren zur herstellung von neuen pyrensulfonsaeurederivaten
DE3884870D1 (de) Verfahren zur Herstellung von Vitamin-D-Derivaten.
ATE124681T1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
AT386197B (de) Verfahren zur herstellung von neuen indolderivaten
AT373914B (de) Verfahren zur stereospezifischen herstellung von d-carbamylderivaten von alpha-hydroxysaeuren
DE3873593D1 (de) Apparatur zur herstellung von halbleiterkristallen.
PT86452A (de) Verfahren zur herstellung der desmalonylverbindung von makrolid-lactonen
ATA10886A (de) Verfahren zur herstellung von neuen proteinderivaten
ATA514879A (de) Verfahren zur herstellung von reiner cyanursaeure
DE69011541D1 (de) Verfahren zur Herstellung von wasserfreiem Gips.
AT379146B (de) Verfahren zur herstellung von n'-(mono- oder disubstituierten)-n-aryl-harnstoff-derivaten
AT383128B (de) Verfahren zur herstellung des 1-aethoxycarbonyloxy-aethylesters von alpha-aminobenzylpenicillin
ATE98292T1 (de) Verfahren zur herstellung von antioxidantzubereitungen.
AT381309B (de) Verfahren zur herstellung von 5z-formen von 2,3,4 -trinor-1,5-inter-m-phenylen-prostacyclinderiva en
ATE69194T1 (de) Vorrichtung zur herstellung von betonbalken.
ATE98215T1 (de) Verfahren zur herstellung von 2-oxo-3aromatischen karbonsaeure-derivaten.
ATE95840T1 (de) Verfahren zur herstellung von vitamin-dderivaten.

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
REN Ceased due to non-payment of the annual fee